An open letter to G20 leaders from the Action for Animal Health coalition.   Even before the COVID-19 pandemic wreaked havoc on our lives, diseases from animals were causing 2.7 million human deaths a year. Over 75% of new human infectious diseases emerge from animals, with zoonotic diseases affecting over 2 billion people. Over the last decade, zoonotic diseases […]

  GALVmed is pleased to announce the appointment of Dr Johnson Ouma as the new Senior Director of Research & Development, effective October 11, 2021. Dr Ouma is a Kenyan research & development professional with over 25 years’ experience in animal health and agricultural research & product development.  He joins GALVmed from the Africa Technical […]

2020 was a year marked by unprecedented disruptions as most of us dealt with the effects of COVID-19-associated health concerns, lockdown restrictions and economic disruption. While the Pandemic caused delays to some of GALVmed’s field work, our team and partners adapted their ways of working and demonstrated remarkable organisational resilience in the face of great […]

An analysis of the impact of Newcastle Disease vaccination in Uganda has demonstrated substantial effect on chicken flock production. Whilst several studies have demonstrated the clear beneficial impact that vaccinating against Newcastle Disease (ND) can have on reducing the frequency and severity of ND outbreaks in poultry, this new study goes one step further and […]

Animal health stakeholders in Kenya have formed an association to promote proper use of animal health products, fair practice in the industry, conduct public awareness, and articulate and address their needs. Launched on 16th August 2019 at Serena Hotel, Nairobi, the Veterinary Input Suppliers Association of Kenya (VISAK) consists of manufacturers, formulators, importers, and distributors […]

We are currently seeking proposals from relevant organisations to set up a new enterprise that will establish an innovative, sustainable smallholder-focused animal health products distribution operation in Ghana, initially, with subsequent extension to Nigeria. For more information visit: Request for proposals for Ghana/Nigeria upstream distribution initiative.

Hester Biosciences Limited through its Veterinary Social Business (VSB) division has recently launched a new initiative to support animal product technology to improve profitability for livestock entrepreneurs. The Livestock and Veterinary Entrepreneurship Development (LiVE) initiative aims to increase awareness of low-cost inputs such as silage and hay making, feed blocks and mineral blocks, as well […]

Last year, Dr Carolin Schumacher joined our team as the new Chief Executive. She recently sat down with industry magazine Animal Pharm to talk about her aspirations and  how she is steering GALVmed towards providing better livestock health services to smallholder farmers. Read more on this insightful interview.  

To commemorate the 2019 World Veterinary Day whose theme was the Value of Vaccination, the Veterinary Social Business (VSB) division of Hester Biosciences Limited, a GALVmed partner in South Asia, recently conducted a weeklong livestock vaccination campaign. The seven-day campaign was an innovative awareness activity on the value of livestock vaccination. The campaign targeted all […]

Inaugural scientific workshop held from 19-20 March 2019 in Nairobi, Kenya During the Keystone Symposia in Cape Town (2016) African scientists set the base for establishing the African Vaccinology Network (AfVANET) as a forum for African scientists to take greater part in establishing priorities for vaccine development for emerging and re-emerging human and veterinary diseases […]